Israeli PolyPid signs $320 million deal to sell drug preventing surgical infections in US, Canada

The Jerusalem Post The Jerusalem Post —

Medications.</p><p>Ilustrative. (photo credit: SHUTTERSTOCK)https://images.jpost.com/image/upload/f_auto,fl_lossy/q_auto/c_fill,g_faces:center,h_720,w_1280/718583" title="Medications.

Ilustrative. (photo credit: SHUTTERSTOCK)" />
D-PLEX100 is designed to provide local, prolonged, and controlled antibacterial activity directly at the surgical site to prevent abdominal surgical site infections.

Read full article at The Jerusalem Post →